First Wave BioPharma Announces Exercise Of Warrants And Issuance Of New Warrants In A Private Placement For $2.4M Gross Proceeds Priced At-The-Market
Portfolio Pulse from Benzinga Newsdesk
First Wave BioPharma (NASDAQ: FWBI) has entered into agreements to exercise existing warrants for 1,681,667 shares at a reduced price of $1.15 per share, in exchange for new warrants. The transaction is expected to generate $2.4 million in gross proceeds.
June 13, 2023 | 4:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
First Wave BioPharma's exercise of existing warrants and issuance of new warrants is expected to generate $2.4 million in gross proceeds.
First Wave BioPharma's exercise of existing warrants and issuance of new warrants will generate $2.4 million in gross proceeds, which can be used to fund the company's operations and development. This is likely to have a positive impact on the stock price in the short term as it indicates increased liquidity and potential for growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100